Esteban, Lyn has given what has been the generally accepted guide PSA figures for some time, although patients are beginning to be treated more on an individually assessed basis and the way cancer advances, not just based on PSA but also taking in MRI and other scans into account as part of more personalized monitoring and histology. There are also differences between Oncologists on how early to administer follow up treatment. If you take my case for example, I had RT with follow up monitoring done at The Royal Marsden. My PSA nadir was 0.05 after a couple of years or so post RT. However, my Oncologist began to be concerned when my PSA reached 1.45 and they had given me an endorectal MRI, which showed a tumour they thought should be treated. I was referred to UCLH for HIFU which was administered when my PSA was 1.99, ie below my nadir of 0.05 plus 2 (2.05). This was partially successful but subsequent PSA and scans showed that not all the tumour had been obliterated or it had regrown. I declined HT and was given a second HIFU in December 2021. This appears to have worked well and the 3 PSA tests I have had this year have all recorded 0.02 which is the lowest figure ever. Notwithstanding this, I was booked in for a scan this month but it has been postponed until next month due to a scanner failure. I am of the opinion that it can make a big difference which hospital and particular consultant takes your case. This will also depend to a greater extent on how widely and quickly advances in scans and treatments can be introduced, leading to some men like myself being treated earlier and more effectively than hitherto.
Edited by member 26 Dec 2022 at 17:50
| Reason: spelling